Company Critical Outcome Technologies Inc. Toronto S.E.
Equities
COT
CA22675B1031
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CAD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
David Sanderson
BRD | Director/Board Member | - | 13-12-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,986,415 | 15,211,245 ( 69.18 %) | 0 | 69.18 % |
Company contact information
Cotinga Pharmaceuticals, Inc.
127 Main Street
02129, Boston
+
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock
- Company Critical Outcome Technologies Inc.